Avient Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Los beneficios de Avient han disminuido a una tasa media anual de -8.5%, mientras que en la industria Chemicals los beneficios disminuyeron en un 4% anualmente. Los ingresos han ido disminuyendo a una tasa media de 1.8% al año. La rentabilidad financiera de Avient es de 6.6%, y sus márgenes netos son de 4.8%.
Información clave
-8.55%
Tasa de crecimiento de los beneficios
-8.56%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.93% |
| Tasa de crecimiento de los ingresos | -1.82% |
| Rentabilidad financiera | 6.59% |
| Margen neto | 4.81% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Apr 22
AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential
Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.Actualización de narrativa • Apr 08
AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential
Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.Actualización de narrativa • Mar 24
AVNT: Future Commodity Cost Management Will Drive ReRating Potential
Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-forwards.Actualización de narrativa • Mar 08
AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares
Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.Actualización de narrativa • Feb 21
AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple
The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.Artículo de análisis • Feb 19
There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings
Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...Seeking Alpha • Feb 18
Avient: Becoming A Better Business
Summary Avient has demonstrated solid operating momentum and resilient execution, with shares enjoying a notable re-rating amid challenging industry conditions. Avient's 2026 outlook targets adjusted EBITDA of $555–$585 million and an adjusted EPS midpoint of $3.05, driven by productivity and innovation, not macro recovery. Leverage has improved to 2.6x, and valuation has expanded to 14x adjusted earnings, reflecting investor confidence in management's strategy and product pipeline. Despite a 30% share price gain in six months, Avient remains reasonably valued, but further upside may prompt position trimming on strength. Read the full article on Seeking Alpha
Nueva narrativa • Feb 16
Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook
Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?Actualización de narrativa • Feb 06
AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple
Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.Actualización de narrativa • Jan 23
AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential
Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.Actualización de narrativa • Jan 08
AVNT: Reset Price View Will Support Future Multiple Expansion
Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.Actualización de narrativa • Dec 23
AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion
Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.Actualización de narrativa • Dec 09
AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease
Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.Actualización de narrativa • Nov 24
AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead
Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.Actualización de narrativa • Nov 07
AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets
Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.Artículo de análisis • Nov 05
Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275
The board of Avient Corporation ( NYSE:AVNT ) has announced that the dividend on 7th of January will be increased to...Artículo de análisis • Oct 12
Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.275 on...Actualización de narrativa • Sep 18
High-Performance Healthcare Materials And Sustainable Polymers Will Create Value
Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.Artículo de análisis • Sep 13
Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors
With a price-to-earnings (or "P/E") ratio of 27.9x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Artículo de análisis • Jul 14
Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?
Key Insights Avient's estimated fair value is US$48.56 based on 2 Stage Free Cash Flow to Equity Current share price of...Artículo de análisis • May 23
Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?
Avient Corporation ( NYSE:AVNT ), might not be a large cap stock, but it saw a significant share price rise of 25% in...Artículo de análisis • May 08
Is Avient (NYSE:AVNT) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Artículo de análisis • Apr 07
Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?
Key Insights Avient's estimated fair value is US$60.06 based on 2 Stage Free Cash Flow to Equity Avient's US$30.43...Artículo de análisis • Mar 23
Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E
With a price-to-earnings (or "P/E") ratio of 20.7x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Seeking Alpha • Mar 22
Avient: Specialty Play Slowly Becomes More Special
Summary Avient Corporation has returned to growth in 2024, with promising projections for 2025, despite past disappointments and mixed earnings metrics. The company, specializing in material solutions, aims for organic growth and 20% EBITDA margins, but hasn't yet achieved these targets. Trading at $38 per share, Avient's valuation appears reasonable, but earnings will again be highly adjusted due to significant charges. While the 2025 outlook is strong, I remain cautious and seek a better entry point before initiating a long position. Read the full article on Seeking AlphaArtículo de análisis • Feb 19
At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?
While Avient Corporation ( NYSE:AVNT ) might not have the largest market cap around , it saw a decent share price...Artículo de análisis • Jan 20
Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Artículo de análisis • Jan 03
An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued
Key Insights Avient's estimated fair value is US$57.96 based on 2 Stage Free Cash Flow to Equity Avient is estimated to...Artículo de análisis • Dec 18
Earnings Tell The Story For Avient Corporation (NYSE:AVNT)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...Artículo de análisis • Nov 18
Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?
Avient Corporation ( NYSE:AVNT ), is not the largest company out there, but it saw a decent share price growth of 13...Seeking Alpha • Nov 13
Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth
Summary AVNT's gross profit margins have improved by over 70% in the last decade, indicating a shift to higher-margin specialty services. The company is focused on deleveraging, with share repurchases on hold until net debt-to-EBITDA reaches 2.5x, despite recent acquisitions. AVNT announced its 14th consecutive annual dividend increase, with a 5% hike, and aims to return to a safer payout ratio by 2026. With projected double-digit EPS growth and a potential P/E Ratio of 20.6x, AVNT is rated as a BUY with an estimated share price of $61.80 by the 2025 year-end. Read the full article on Seeking AlphaArtículo de análisis • Nov 02
Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.27 on...Artículo de análisis • Sep 26
Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Nueva narrativa • Sep 02
Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth
Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.Artículo de análisis • Aug 03
A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)
Key Insights Avient's estimated fair value is US$37.54 based on 2 Stage Free Cash Flow to Equity With US$42.83 share...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Avient. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 3,281 | 158 | 687 | 0 |
| 31 Dec 25 | 3,260 | 82 | 701 | 0 |
| 30 Sep 25 | 3,246 | 113 | 707 | 0 |
| 30 Jun 25 | 3,255 | 119 | 713 | 0 |
| 31 Mar 25 | 3,238 | 100 | 720 | 0 |
| 31 Dec 24 | 3,240 | 170 | 713 | 0 |
| 30 Sep 24 | 3,213 | 149 | 689 | 0 |
| 30 Jun 24 | 3,151 | 116 | 666 | 0 |
| 31 Mar 24 | 3,126 | 104 | 659 | 0 |
| 31 Dec 23 | 3,143 | 76 | 672 | 0 |
| 30 Sep 23 | 3,214 | 31 | 715 | 0 |
| 30 Jun 23 | 3,284 | -1 | 709 | 0 |
| 31 Mar 23 | 3,350 | 39 | 691 | 0 |
| 31 Dec 22 | 3,397 | 83 | 653 | 0 |
| 30 Sep 22 | 3,414 | 108 | 631 | 0 |
| 30 Jun 22 | 3,408 | 169 | 639 | 0 |
| 31 Mar 22 | 3,045 | 137 | 631 | 0 |
| 31 Dec 21 | 3,316 | 152 | 661 | 0 |
| 30 Sep 21 | 3,506 | 218 | 655 | 0 |
| 30 Jun 21 | 3,612 | 186 | 665 | 0 |
| 31 Mar 21 | 3,693 | 178 | 617 | 0 |
| 31 Dec 20 | 2,215 | 71 | 506 | 0 |
| 30 Sep 20 | 2,904 | 64 | 474 | 0 |
| 30 Jun 20 | 2,685 | 86 | 418 | 0 |
| 31 Mar 20 | 2,824 | 86 | 442 | 0 |
| 31 Dec 19 | 2,863 | 76 | 486 | 0 |
| 30 Sep 19 | 2,881 | 68 | 483 | 0 |
| 30 Jun 19 | 2,905 | 77 | 474 | 0 |
| 31 Mar 19 | 2,730 | 62 | 452 | 0 |
| 31 Dec 18 | 2,881 | 88 | 456 | 0 |
| 30 Sep 18 | 3,005 | 124 | 451 | 0 |
| 30 Jun 18 | 3,094 | 132 | 450 | 0 |
| 31 Mar 18 | 3,335 | 173 | 457 | 0 |
| 31 Dec 17 | 2,590 | 111 | 419 | 0 |
| 30 Sep 17 | 3,124 | 173 | 416 | 0 |
| 30 Jun 17 | 3,052 | 176 | 403 | 0 |
| 31 Mar 17 | 2,996 | 176 | 389 | 0 |
| 31 Dec 16 | 2,939 | 166 | 390 | 0 |
| 30 Sep 16 | 3,020 | 134 | 418 | 0 |
| 30 Jun 16 | 3,115 | 136 | 422 | 0 |
| 31 Mar 16 | 3,243 | 153 | 425 | 0 |
| 31 Dec 15 | 2,929 | 148 | 394 | 0 |
| 30 Sep 15 | 3,471 | 127 | 455 | 0 |
| 30 Jun 15 | 3,588 | 115 | 466 | 0 |
Ingresos de calidad: AVNT tiene una única gran pérdida de $68.8M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: Los actuales márgenes de beneficio (4.8%) de AVNT son superiores a los del año pasado (3.1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de AVNT han disminuido en un 8.5% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de AVNT en el último año (58%) supera su media de 5 años (-8.5% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de AVNT en el último año (58%) superó al de la industria Chemicals 0.1%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AVNT (6.6%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/29 10:09 |
| Precio de las acciones al final del día | 2026/05/29 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Avient Corporation está cubierta por 18 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Ghansham Panjabi | Baird |
| Prashant Juvekar | Citigroup Inc |
| David Begleiter | Deutsche Bank |